Skip to main content
Premium Trial:

Request an Annual Quote

For Fetal Hemoglobin

A study using a CRISPR-based approach to treat sickle-cell disease has reported promising results, the Associated Press reports.

Last year, Vertex Pharmaceuticals and CRISPR Therapeutics launched a study in which doctors isolated cells from patients' bone marrow and edited them to produce the fetal version of hemoglobin, before re-introducing the cells to patients. About a year after treatment, study participant Victoria Gray told NPR she was doing well and was producing fetal hemoglobin.

The AP notes additional data from the study have now been presented at the American Society of Hematology conference and published in the New England Journal of Medicine. In NEJM, Sarah Cannon Center for Blood Cancer's Haydar Frangoul and his colleagues report that two patients from their study, one with sickle-cell disease and one with β-thalassemia, have had sustained increases in fetal hemoglobin levels. Frangoul and his colleagues note they have since treated a further eight patients with similar results.

"The preliminary results are extremely encouraging," Frangoul tells the AP.

In a separate NEJM paper, researchers from Harvard Medical School report on their study of six patients with severe sickle cell disease who they treated using a shRNA targeting the same gene. They too report that their patients had increased fetal hemoglobin levels.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.